Ann: Investor Update and Notice of Investor Briefing, page-2

Ok.., finally a structure to the madness.
Pending resolutions, a re structure of approximately 55mil share registry at 50 cent to $1 range with 70% owed by the Cho group.
Positives?
Possibility of current pipeline re-activated via CR ( yes, new interest by yet existing shareholders to be). Yes, at this estimated SP, a CR will be seen as the way to progress existing assets, especially known to be clinically significant.
Company continues to exist.
As previously stated, will revisit next year..., could be a rebirth via restructuring..., who knows.
Ps. Nice presentation (finally).